AI Article Synopsis
- - Proton therapy is a new and debated treatment for prostate cancer that offers benefits over traditional photon radiation therapy but comes with higher costs for patients and insurers.
- - Studies have shown that proton therapy can be effective and safe for patients with localized prostate cancer, as well as those needing additional pelvic radiation after surgery.
- - The PTCOG's Genitourinary Subcommittee aims to evaluate the uses, pros, cons, and cost-effectiveness of proton therapy, alongside discussing ongoing clinical trials, to inform clinical practices and future research.
Article Abstract
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489490 | PMC |
| http://dx.doi.org/10.14338/IJPT-20-00031.1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!